Rui Fan
Xiamen, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
KHDRBS1 as a novel prognostic signaling biomarker influencing hepatocellular carcinoma cell proliferation, migration, immune microenvironment, and drug sensitivity.
Journal: Frontiers in immunology
Published: February 29, 2024
Prediction of carbon emissions from public buildings in China's Coastal Provinces under different scenarios --A case study of Fujian Province.
Journal: PloS one
Published: November 14, 2023
Downregulation of dermatopontin in cholangiocarcinoma cells suppresses CCL19 secretion of macrophages and immune infiltration.
Journal: Journal of cancer research and clinical oncology
Published: September 29, 2023
Trilobolide-6-O-isobutyrate exerts anti-tumor effects on cholangiocarcinoma cells through inhibiting JAK/STAT3 signaling pathway.
Journal: Heliyon
Published: August 11, 2023
RARγ promotes the invasion and metastasis of thyroid carcinoma by activating the JAK1-STAT3-CD24/MMPs axis.
Journal: International immunopharmacology
Published: August 10, 2023
DPY30 Promotes Proliferation and Cell Cycle Progression of Colorectal Cancer Cells via Mediating H3K4 Trimethylation.
Journal: International journal of medical sciences
Published: October 21, 2022
Diosgenin exerts anti-tumor effects through inactivation of cAMP/PKA/CREB signaling pathway in colorectal cancer.
Journal: European journal of pharmacology
Published: February 08, 2021
Trilobolide-6-O-isobutyrate suppresses hepatocellular carcinoma tumorigenesis through inhibition of IL-6/STAT3 signaling pathway.
Journal: Phytotherapy research : PTR
Published: January 30, 2021
Showing 1-8 of 8
Last Updated: 09/26/2026